Tag Archive for: EpiEndo Pharmaceuticals

drug development

EpiEndo Pharmaceuticals pushes COPD candidate

EpiEndo Pharmaceuticals ehf got the green light for a Phase IIa COPD trial with its non-anbibiotic macrolide EP395

Read more